A Novel Class of RanGTP Binding Proteins

Purification of RanBP7 and Binding Assays

For small scale purification, 100 μl of a Xenopus egg extract (plus energy-regenerating system) was diluted 10-fold in binding buffer (50 mM Tris/ HCl, pH 7.5, 200 mM NaCl, 10 mM magnesium acetate), and a post-ribosomal supernatant was prepared. This was rotated overnight with 20 μl IgG Sepharose to which a z-tagged IBB domain (Görlich et al., 1996a ) had been prebound. The nonbound fraction was removed, and the beads were washed six times in binding buffer plus 0.005% digitonin, including a 1-h wash step. Bound proteins were eluted with 1 M magnesium chloride plus 50 mM Tris/HCl, pH 7.5, and precipitated with 90% isopropanol (final). For sequence analysis, the purification was scaled up 50 times and performed in a column mode. The bound proteins were separated on an SDS gel and visualized by Coomassie staining. The RanBP7 band was excised and digested with trypsin. Peptides were separated by HPLC, and several peaks were sequenced. Analysis of human RanBP7 was essentially the same, except that a 50 μg/ml digitonin extract from HeLa cells (for small scale) or a HeLa extract prepared by mild sonication (large scale) was used as the starting material. The binding to the BSA-NLS conjugate has been described previously (Görlich et al., 1996a ). The other analytical binding assays were performed analogous to the small-scale binding described above. Material bound to z–importin-β or z-RanBP7 was eluted with SDS instead of magnesium chloride. Additional modifications are described in the legends.

Antibodies

Antibodies were raised in rabbits against recombinant Xenopus RanBP7. Affinity purification was on sulfo-Link (Pierce, Rockford, IL) to which RanBP7 had been coupled. The anti-RanBP7 antibody is monospecific on blots with total Xenopus egg extract (not shown). Antibodies against importin-α, importin-β, and Ran have been described before (Görlich et al., 1995 b ).

Molecular Cloning

Based on the partial peptide sequences obtained from RanBP7, two degenerate oligonucleotides AA(AG)ATGAT(TCA)GA(AG)AA(AG)CA (TC)GG and AA(AG)GCNAT(TCA)TT(TC)CA(AG)AA(AG) were synthesized and used to identify full length cDNA clones in a Xenopus oocyte cDNA library. For expression and in vitro translation, RanBP7 was cloned into the pQE70 (Qiagen, Hilden, Germany), zz70, and T7-70 vectors (see below). Comparison of the Xenopus RanBP7 sequence with the GenBank/EMBL/DDBJ database identified a similar cDNA-clone (IMAGE Consortium clone ID34250; ACC 360021; Lennon et al., 1996) that was subsequently shown to code for the NH₂ terminus of human RanBP8. The sequence information of the complete coding region of RanBP8 was obtained by 3′ race (Primer: GGATGAAGAGCTGTGGCAAGAAGATCC and Oligo dT₁₈) using KlenTaq enzyme (Clontech Laboratories, Palo Alto, CA) and a human cDNA as a template. The human cDNA was prepared from HeLa cell mRNA using the direct mRNA kit (OligoTex; Qiagen) and a cDNA synthesis kit (Great Length cDNA Kit; Clontech Laboratories).

The complete coding sequence of human RanBP8, human CAS, and human transportin were amplified by PCR from HeLa cDNA and cloned into the NcoI/BamH1 sites of pQE60 or zz60. The zz60 vector was generated by an in-frame insertion into the NcoI site of pQE60 of a BspHI/ NcoI fragment containing two z domains from protein A. The DNAs encoding Cse1p, Pse1p, Pdr6p, or the NH₂-terminal 682 amino acids of Msn5p were obtained by PCR amplification from genomic Saccharomyces cerevisiae DNA, using primers containing the appropriate restriction sites for subsequent cloning into expression vectors. Cse1p was cloned into the NcoI/BamHI sites of z60, Pdr6p, and the Msn5p fragment, and the Pse1p fragments were cloned into SphI/BamHI sites of zz70 (a pQE70 derivative in which two z domains are fused in front of the multi-cloning site).

Sequence Analysis and Homology Searches

RanBP7 was subjected to a variety of sequence analysis tools (Bork and Gibson, 1996). Database searches with the Blast series of programs (Altschul et al., 1994) revealed significant similarity with RanBP8 (described in this paper), Nmd5p, D9509.15p, HRC1004p (an open reading frame from S. cerevisiae), CAS (Brinkmann et al., 1995), Cse1p (Xiao et al., 1993), and Lph2p. These were aligned using Clustal W (Thompson et al., 1994) and Macaw (Schuler et al., 1991). The most significant blocks accumulated in the first 150 residues of these proteins. To identify more distant members of this new family, iterative profile searches (Birney et al., 1996; Bork and Gibson, 1996) were performed based on an alignment of the conserved NH₂-terminal region. New members of this emerging family were accepted and incorporated into the profile for the next iteration when (a) their scores were higher than 5,000, (b) they were clearly separated from the first false positive, and (c) when the profile matched the NH₂ terminus of the respective sequence. Each newly identified member was subjected to reciprocal database searches (Bork and Gibson, 1996). This procedure left several putative homologues in the “twilight zone” of the profile search method applied (Birney et al., 1996) and the superfamily described here might be even larger.

The sequence data for the following aligned proteins are available from GenBank/EMBL/DDBJ under accession numbers given: Xenopus RanBP7, U71082; human RanBP8, U77494; human CAS, U33268; S. cerevisiae Cse1p, P33307; S. cerevisiae Lph2p, U43503; S. cerevisiae Nmd5p, P46970; S. cerevisiae D9509.15p, U32274; S. cerevisiae Yrb4p, P40069; human importin-β, L38951; S. cerevisiae importin-β, U19028; S. cerevisiae HRC1004, S53939; human RanBP5, Y08890; S. cerevisiae Pse1p, P32337; S. cerevisiae Crm1p, P30822; S. cerevisiae Mtr10p, U55020; C. elegans C49h3.7, U42436; S. cerevisiae Los1p, P33418; S. cerevisiae Msn5p, X93302; C. elegans T16g12.3, Z30317; S. cerevisiae Pdr6p, P32767, Schizosaccharomyces pombe Crm1p, p14068, S. pombe HRC1004, z69730.

In Vitro Translation

Importin-β and human transportin were cloned into the T7-60 vector, Xenopus RanBP7 into T7-70. T7-60 and -70 are pQE60 and pQE70 derivatives, respectively, in which the promoter/RBS elements were replaced by a T7 promoter and the 5′ untranslated region from Xenopus β globin to enhance translation efficiency. Labeled proteins were generated by coupled transcription/translation in the reticulocyte TNT system (Promega Biotech, Madison, WI) for 2 h at 30°C.

Oocyte Injections

To study nuclear export, RanBP7 was translated in vitro and injected into nuclei of Xenopus oocytes as described (Kambach and Mattaj, 1992). Two internal injection controls for nuclear integrity were used: the hemoglobin from the reticulocyte lysate, and ¹⁴C-labeled BSA (Amersham Buchler, Braunschweig, Germany) which was coinjected. The distribution of endogenous proteins in total oocytes, nuclear, and cytoplasmic fractions was determined by SDS-PAGE followed by Coomassie staining or Western blotting.

Microinjection of RNA and analysis by denaturing gel electrophoresis and autoradiography were performed as described (Jarmolowski et al., 1994). The concentration of the recombinant importin-β and RanBP7 in the injected samples was ∼40 μM. The mutant RNAs used (U1ΔSm, U5ΔSm) lack protein binding sites required for the nuclear reimport of these RNAs and thus remain in the cytoplasm after export from the nucleus. U6Δss RNA is not exported and is used as an internal control for nuclear injection.

Expression and Purification of Recombinant Proteins

The expression and purification of the following factors was as described previously: importin-β, nucleoplasmin core domain, z-tagged IBB domain from Xenopus importin-α (Görlich et al., 1996a ), NTF2 (Kutay et al., 1997), Ran, RanBP1, and S. pombe Rna1p (Bischoff et al., 1995a , b ). z-Tagged RanBP1 was expressed from the zz60 vector and purified via a COOH-terminal his-tag. RanQ69L was expressed from pQE32 (Qiagen) and purified on nickel-NTA agarose (Qiagen), and after nucleotide exchange for GTP, RanQ69L was concentrated on SP Sepharose FF (Pharmacia, Uppsala, Sweden). For transport studies, S. pombe Rna1p was expressed from pQE60 or zz60, and its enzymatic activity was verified by a GAP assay. For some experiments, importin-β was expressed with an NH₂-terminal z-tag and purified on an IBB domain coupled to sulfoLink, followed by gel filtration on Superdex 200 (Pharmacia). RanBP7 and RanBP8 were expressed with COOH-terminal his-tags from the pQE70 and pQE60 vectors, respectively. For some experiments two z-domains were fused to their NH₂ termini. Expression of RanBP7 and RanBP8 was in the BLR/ Rep4 strain at 15°C, and purification was on nickel agarose followed by chromatography on MonoQ. Pse1p, Cse1p, CAS, Msn5p, and Pdr6p were expressed with NH₂-terminal z-tags.

Transportin was expressed at 15°C with a COOH-terminal his-tag, with or without an NH₂-terminal z-tag. Purification was with nickel agarose followed by chromatography on MonoQ (Pharmacia). Activity was verified in an import assay using a fluorescent nucleoplasmin core-M9 fusion as a substrate.

Fluorescence Labeling

Labeling of importin-β has been described before (Kutay et al., 1997). RanBP7 and transportin were labeled with fluorescein 5′ maleimide as follows: the recombinant proteins were purified on nickel agarose and MonoQ, omitting DTT and mercaptoethanol during the MonoQ step. The protein concentration was estimated from the UV absorbance at 280 nm (Edelhoch, 1967) and fluorescein 5′ maleimide, dissolved in dimethylformamide, and was added at a 1:1 molar ratio. The reaction was allowed to proceed for 4 h on ice, quenched with 50 mM mercaptoethanol, and the labeled proteins were purified on a Superdex 200 HR column equilibrated in 20 mM Hepes/KOH, 80 mM potassium acetate, 3 mM magnesium acetate. Human IgG was labeled with Fluos (Boehringer Mannheim, Mannheim, Germany) and purified on Superdex 200.

NPC Binding Assay

The binding assay was essentially performed as an import assay with permeabilized cells as described earlier (Görlich et al., 1996a , b ). The binding buffer contained 20 mM Hepes/KOH, pH 7.5, 140 mM potassium acetate, 4 mM magnesium acetate, 1 mM DTT, 250 mM sucrose, and 2 mg/ml nucleoplasmin core, 2 mg/ml BSA, plus 1 mg/ml aprotinin to block nonspecific binding, 1.5 μM Ran (GDP form), 150 nM RanBP1, 150 nM Rna1p, 150 nM NTF2, and an energy-regenerating system containing 0.5 mM GTP and ATP, 10 mM creatine phosphate, and 50 μg/ml creatine kinase. Binding to the NPC was allowed for 10 min at room temperature. The other details are given in the legend. The nuclei were fixed with paraformaldehyde/glutaraldehyde, spun onto coverslips, and analyzed by confocal microscopy.

Enzymatic Assays

Labeling of Ran with γ-[³²P]GTP, GTPase, and nucleotide exchange assays were performed as described (Bischoff et al., 1994, 1995b ; Görlich et al., 1996b ; Kutay et al., 1997). The reactions were performed in 20 mM Hepes/KOH, pH 7.4, 100 mM NaCl, 1 mM MgCl₂, 1 mM sodium azide, 0.05% hydrolyzed gelatin.

Overlay Blots

The basic method followed a published protocol (Lounsbury et al., 1994, 1996) with some modifications. Briefly, proteins were separated by SDS-PAGE and transferred onto nitrocellulose. The blot was then incubated for 1 h at 4°C in renaturation buffer containing 20 mM MOPS, pH 7.1, 100 mM sodium acetate, 5 mM magnesium acetate, 5 mM dithiothreitol, 0.5% bovine serum albumin, 0.05% Tween 20, and subsequently for 30 min at 25°C in renaturation buffer plus 100 μM unlabeled GTP (10 ml total volume). After 10 min, 100 μl of 1 nM Ran γ-[³²P]GTP was added alone or with either 5 μM RanBP1 or importin-β. After a further 10 min the blot was washed five times in renaturation buffer and subjected to autoradiography at −70°C. Overlays with Gsp1p were performed the same way as with Ran.

Identification of RanBP7 as Copurifying with Importin-β

The IBB domain is that part of importin-α to which the β subunit binds with high affinity. At high salt concentrations, importin-β appears to bind from a complete cytosol as a single polypeptide to an immobilized IBB domain (Görlich et al., 1996a , b ). At more physiological ionic strength (200 mM), however, a second band of 120 kD copurifies reproducibly (Fig. 1 A, lane 2). The binding of importin-β and the 120-kD protein to the IBB domain is highly specific by a number of criteria. First, binding requires a functional IBB domain (not shown). Second, the binding of both polypeptides is sensitive to RanGTP. RanGTP binds to importin-β and thereby prevents interaction with importin-α or the IBB domain. We used here the GTPase-deficient RanQ69L mutant which remains in its GTP-bound form, even in the presence of the cytoplasmic RanGAP1 (Klebe et al., 1995). If 10 μM RanQ69L GTP was added to the starting material, neither importin-β nor the 120-kD protein was recovered in the bound fraction (Fig. 1 A, lane 3). Third, binding is competed by excess of the nonimmobilized IBB domain (Fig. 1 B, lane 4). For reasons detailed below, we will refer to the 120-kD protein as Ran binding protein 7 (RanBP7). To facilitate further analysis, we obtained partial peptide sequences from RanBP7, used this information to clone the corresponding gene from a Xenopus oocyte cDNA library, and expressed RanBP7 in Escherichia coli. The RanBP7 sequence and its homologies to other proteins are discussed below.

The finding that RanBP7 copurifies with importin-β on an IBB column can be explained in two ways. First, importin-β and RanBP7 could each bind independently to the IBB domain, or, secondly, RanBP7 could bind via importin-β. To distinguish between these possibilities, we subjected a lysate from E. coli expressing RanBP7 to binding to an IBB column. As seen from Fig. 1 B, RanBP7 was recovered in the bound fraction only when importin-β was added. Thus, RanBP7 binds to the IBB domain via importin-β and is therefore an importin-β binding protein.

To find out whether the expression of RanBP7 is restricted to Xenopus oocytes or also common to other tissues, we raised antibodies against recombinant RanBP7 and found them to cross-react with a 120-kD protein in a variety of cells, including HeLa cells. Furthermore, the complex of RanBP7 and importin-β can be purified on an immobilized IBB domain from a HeLa cell extract in the same way as from an egg extract (Fig. 1 C). The identity of the copurifying 120-kD polypeptide was verified in two ways: by Western blotting using affinity purified anti-RanBP7 antibodies and by peptide sequencing of the 120-kD band, where all 52 residues of obtained partial sequence matched human RanBP7 (not shown).

RanBP7 Is a Novel Ran-Binding Protein

Mammalian cells contain a number of Ran-binding proteins that can be detected by overlay blots using Ran loaded with [³²P]GTP as a probe (Coutavas et al., 1993; Lounsbury et al., 1994, 1996). These Ran-binding proteins fall into two classes. The first class includes those containing a RanBP1 homology domain whose Ran binding is competed by RanBP1, i.e., RanBP1 itself (23 kD; Coutavas et al., 1993), and RanBP2 (358 kD; Wu et al., 1995; Yokoyama et al., 1995). In contrast, the signals of the second class comprising 90- and 120-kD bands cannot be competed with RanBP1. The signal is even further enhanced when the blot is probed with the RanBP1/RanGTP complex (Lounsbury et al., 1996; Kutay et al., 1997). The 90-kD band corresponds to importin-β and is recovered in the IBB-bound fraction (Fig. 1 D). The 120-kD protein which copurifies with importin-β, also gives a significant signal in the overlay. It is therefore RanGTP binding and referred to as Ran binding protein 7.

It should be noted that the 120-kD band in the total HeLa extract actually represents a mixture of different Ran-binding proteins (RanBPs) of similar size. Besides RanBP7, it includes at least one additional protein called RanBP5 (Deane et al., 1997) and probably also RanBP8 (see below). Further candidates are RanBP4 and RanBP6 (Hartmann, E., unpublished observations), which are human homologues to the S. cerevisiae proteins Yrb4p (Schlenstedt, G., E. Smirnova, R. Deane, J. Solsbacher, U. Kutay, D. Görlich, H. Ponstingl, and F.R. Bischoff, manuscript submitted for publication) and Pse1p, respectively. However, of these, only RanBP7 appears to be recovered in the IBB-bound fraction, as judged by microsequencing of the 120-kD band (not shown).

The RanBP7–Importin-β Interaction Appears Unrelated to NLS-mediated Protein Import

Because importin-β is a key mediator of NLS-mediated nuclear protein import, we wanted to know if it interacts with RanBP7 to promote this process. In this case, a quaternary NLS/importin-α/β/RanBP7 complex should be the active species. However, the experiment shown in Fig. 2 A makes this assumption unlikely: only importin-α and -β, but hardly any RanBP7, copurify on an immobilized BSA-NLS conjugate. Consistent with that, RanBP7 does not stimulate import of nucleoplasmin into nuclei of permeabilized cells (not shown). One possibility would be that importin-β binds RanBP7 to modify its substrate specificity. This could then allow the transport of cargoes that carry signals other than a classical NLS. Alternatively, the heterodimer might form to regulate importin-β and/or RanBP7 function.

The RanBP7/Importin-β Complex Is Dissociated by RanGTP

The RanBP7/importin-β heterodimer can be formed by binding importin-β from a Xenopus egg extract to z-tagged RanBP7 (Fig. 2 B). In this case, binding of Ran is not observed, probably because the extract contains Ran only in its GDP-bound form for which RanBP7 has no detectable affinity (see below). If RanQ69L GTP that is stabilized in the GTP-bound form is added to the starting material, then two effects are observed. First, Ran is now recovered in the RanBP7-bound fraction, confirming RanBP7 as a RanGTP-binding protein. Second, the formation of the RanBP7/importin-β complex is prevented.

To show that RanGTP can also dissociate a preformed RanBP7/importin-β complex, we performed the experiment shown in Fig. 2 C. RanBP7 was expressed in E. coli and bound to importin-β that was immobilized on IgG Sepharose via a z-tag. SDS elutes both RanBP7 and z–importin-β from the column. When the elution was performed with RanGTP, z–importin-β remained matrix bound, however RanBP7 was dissociated from importin-β and recovered in the eluate (Fig. 2 C). Thus, the RanBP7/importin-β complex does not form in the presence of RanGTP. Furthermore, a preformed complex is dissociated by RanGTP addition.

Sequence and Homologies of RanBP7

The Xenopus RanBP7 cDNA codes for a protein of 119 kD. The peptide sequences from HeLa RanBP7 and a human RanBP7 sequence tag (Acc R49703) indicate that human RanBP7 is ∼95% identical to the Xenopus protein. On the basis of an expressed sequence tag we have also cloned another relative, RanBP8, which is a human protein with 61% identity to RanBP7 (Fig. 3).

Database searches with the Blast series of programs (Altschul et al., 1994) revealed significant similarity of RanBP7 and RanBP8 to S. cerevisiae Nmd5p (26% identity; Fig. 3), S. cerevisiae D9509.15p, and a number of further proteins of similar length, i.e., 95–130 kD. In the multiple alignment of these sequences (Schuler et al., 1991; Thompson et al., 1994) the most significant blocks were found within the NH₂-terminal 150 residues of each protein.

RanBP7 Shares a Common NH₂-terminal Sequence Motif with a Protein Superfamily that Includes Importin-β

To identify more distant members of this new family, iterative profile searches (Birney et al., 1996; Bork and Gibson, 1996) were performed based on an alignment of the conserved NH₂-terminal region (for details see Materials and Methods section). The results of the procedure are shown in Fig. 4 A. They included more than 20 sequences from different eukaryotes, such as human and yeast importin-β, S. cerevisiae Cse1p, human CAS, S. cerevisiae Crm1p, Nmd5p, etc. This protein superfamily consists of several subgroups, as indicated in Fig. 4 B. The cellular functions attributed to these proteins appear very diverse, but it is possible that all relate to nuclear function. For example, importin-β is the key mediator of NLS-dependent nuclear protein import, while Cse1p has been shown to be required for the destruction of B-type cyclins in the yeast nucleus (Irniger et al., 1995), and human CAS appears to be required for cell proliferation and apoptosis (Brinkmann et al., 1995). Mtr10 was found in a genetic screen for mutants defective in mRNA export from the yeast nucleus (Kadowaki et al., 1994). We reasoned that the common sequence motif in these proteins might relate to a common function.

The Conserved NH₂-terminal Motif Appears to Account for Interaction with RanGTP

The region of high similarity comprises residues 1–150 in importin-β. We recently mapped the Ran binding domain in importin-β to the NH₂-terminal 364 residues (Kutay et al., 1997). The NH₂-terminal region from the profile search appears to constitute the conserved core of this domain. That the experimentally found Ran binding domain is larger than the stretch of conserved amino acids can be explained with the need for folding to bring the key residues into the proper spatial position. The conservation profile suggests that these proteins might be targets of Ran function. In this case one would not only predict that proteins like Pse1p and Cse1p bind Ran (or Gsp1p, the yeast Ran, respectively; Belhumeur et al., 1993) but also that the interaction is mediated by the NH₂ termini of these proteins. To test the predictions for at least some of the candidates, we expressed human CAS and the yeast proteins Pse1p, Cse1p, Msn5p, and Pdr6p in E. coli, separated the lysates by SDS-PAGE, transferred the proteins onto nitrocellulose, and probed for Ran interaction using Ran (or yeast Gsp1p) charged with labeled GTP as a probe.

The first protein tested for Ran binding is human CAS. We probed this blot with Ran γ-[³²P]GTP in the presence of a 5,000-fold excess of RanBP1. This procedure detects Ran-binding proteins of the importin-β type but not Ran binding proteins like RanBP1 or RanBP2. As seen from Fig. 5 A, a control lysate expressing importin-α which does not bind Ran, is negative, but the recombinantly expressed CAS protein gives a positive signal, just as importin-β. The CAS–RanGTP interaction is strongly competed by importin-β (not shown). Thus, human CAS binds RanGTP in a similar way as importin-β.

We next tested Ran binding to full length Pse1p (Chow et al., 1992) and NH₂-terminal fragments of Pse1p from S. cerevisiae using γ-[³²P]GTP loaded Gsp1p, the Ran homologue of S. cerevisiae. Fig. 5 B shows that full length Pse1p and its 409 NH₂-terminal amino acids are positive in this Ran-binding assay. The binding is specific, as it is only observed with the GTP form of Gsp1p and is competed by yeast importin-β (not shown). The NH₂-terminal 257 residues, however, are not sufficient to give a significant signal. Thus, the Gsp1 (Ran)-binding domain of yeast Pse1p maps approximately as the Ran binding domain of importin-β (the NH₂-terminal 364 amino acids are required for Ran binding). The same figure also demonstrates the Gsp1p binding activity of S. cerevisiae Cse1p (Xiao et al., 1993) and Msn5p (ACC X93302), whereas Pdr6p (Chen et al., 1991), which also came up in the profile search (Fig. 4), and the control lysates gave no signal.

Effects of RanBP7 and RanBP8 on the RanGTPase

Having identified an entire class of novel targets for Ran function, we wanted to investigate the interaction of a representative of this class with Ran in more detail. Ran can cycle between a GDP and GTP-bound state, where the intrinsic rates of nucleotide exchange and GTP hydrolysis are very low. Catalysis by specific factors can increase these rates up to 10⁵-fold (Bischoff and Ponstingl, 1991a ; Bischoff et al., 1994, 1995a ; Becker et al., 1995; Klebe et al., 1995). The major GTPase activating protein is cytoplasmic RanGAP1 (Rna1p in yeast); the principal GTP/GDP exchange factor is RCC1.

Fig. 6 A shows that RanBP7 and RanBP8 inhibit, like importin-β (Floer and Blobel, 1996; Görlich et al., 1996b ), the GAP stimulation of the Ran GTPase. From the dose dependence one can estimate the affinities of these factors for RanGTP. The dissociation constant from RanGTP is ∼25 nM for RanBP7, 4 nM for RanBP8, and 0.8 nM for importin-β, measured under identical conditions. It should be noted that RanBP7 and RanBP8 also inhibit the intrinsic GTPase activity of Ran (not shown).

Fig. 6 B shows that RanBP8 inhibits the RCC1-mediated nucleotide exchange on RanGTP (RanBP7 has the same effect, not shown). The effect is specific for the GTP form; RanGDP is not affected. RanBP8 and RanBP7 thus behave like importin-β (Görlich et al., 1996b ) in this assay.

Like importin-β, RanBP7 and RanBP8 can each form a trimeric complex with RanGTP and RanBP1. These complexes are evident by gel filtration (not shown) or by affinity chromatography. For example, Fig. 6 C shows that RanBP7 can bind via RanGTP to immobilized RanBP1. RanBP1 has a striking effect on both the RanBP7/RanGTP and the RanBP8/RanGTP complex in that it relieves their GAP resistance (Fig. 6 D). RanBP1 is thus a cofactor for the disassembly of these complexes. This might well be one in vivo function of RanBP1. It should be noted that the one clear difference between importin-β and RanBP7/8 is that the RanBP1/RanGTP/importin-β complex is still GAP resistant (Görlich et al., 1996b ), and its disassembly requires at least one additional factor (Bischoff, F.R., unpublished results).

RanBP7 Can Shuttle between Nucleus and Cytoplasm

RanBP7 is, at steady state, a predominantly cytoplasmic protein (see below). To test if it can cross the nuclear envelope like importin-β, we translated RanBP7 in vitro in the presence of [³⁵S]methionine and injected the mixture into nuclei of Xenopus oocytes. We used two internal controls for nuclear integrity, the hemoglobin from the reticulocyte lysate, which is not exported and clearly visible in the injected nuclei (not shown), and ¹⁴C-labeled BSA (“injection control”). After 5 or 90 min, the oocytes were dissected into nuclear and cytoplasmic fractions, which were analyzed for the presence of the labeled proteins. As seen from Fig. 7 A, RanBP7 is rapidly exported from the nuclei, and a significant proportion reached the cytoplasm already after 5 min. After 90 min the steady state distribution was reached in which 90–95% of RanBP7 is cytoplasmic.

We next wanted to know if the nuclear export of RanBP7 is active and dependent on specific factors. As RanBP7 is a Ran-binding protein, we reason that its interaction with Ran might be crucial for its transport across the nuclear envelope. As detailed in the introduction, there is a strikingly asymmetric distribution of the Ran system. The GDP/GTP exchange factor RCC1, which loads Ran with GTP, is exclusively nuclear. Its antagonist, the GTPase-activating protein RanGAP1 is excluded from the nucleoplasm and depletes RanGTP from the cytoplasm. As a consequence, the RanGTP concentration should be high in the nucleus and very low in the cytoplasm. We wanted to know if the breakdown of this RanGTP gradient would affect the nuclear export of RanBP7. To deplete the nuclear RanGTP pool, we injected Rna1p (RanGAP1 from S. pombe) into nuclei of Xenopus oocytes. As seen from Fig. 7 A, this treatment severely reduced the rate of RanBP7 export. Strikingly, export was restored if the Rna1p-resistant RanQ69L mutant (GTP form) was prebound to RanBP7 before nuclear injection. Two conclusions are suggested from this experiment. First, RanBP7 requires nuclear RanGTP for export, and second, RanBP7 is exported out of the nucleus as a complex with RanGTP. This also excludes the possibility that RanBP7 leaves the nucleus by simple diffusion. Because RanGTP dissociates RanBP7 from importin-β (Fig. 2, B and C), we can also exclude that RanBP7 is exported by importin-β.

At a steady state, RanBP7 is 90–95% cytoplasmic, and 5–10% are found in the nuclear fraction (Fig. 7 B, control). If this distribution reflects the dynamics of import and export, then endogenous RanBP7 should shift to the nucleus if its re-export from the nucleus is inhibited by a nuclear injection of Rna1p (S. pombe RanGAP1). As seen from Fig. 7 B this treatment does not change the localization of any of the major cytoplasmic proteins (Fig. 7 B, Coomassie), however, ∼50% of the total RanBP7 are indeed chased into the nucleus. Considering that the nucleus has only 1/10 of the volume of the cytoplasm, this is not just equilibration between nucleus and cytoplasm but rather is a 10-fold accumulation in the nuclei. The treatment also causes an increase in nuclear importin-α. This is consistent with data in S. cerevisiae (Koepp et al., 1996) showing that SRP1p (yeast importin-α) accumulates in the nucleus if Prp20p (yeast nucleotide exchange factor for Ran) is defective, which probably also causes a decrease in the nuclear RanGTP concentration. This would suggest that the export of importin-α and RanBP7 requires a higher nuclear RanGTP concentration than their import.

RanBP7 and RanBP8 Bind to Nuclear Pore Complexes

Having shown that RanBP7 can cross the nuclear envelope, we wanted to know whether RanBP7 makes a direct contact to nuclear pores. To test this, permeabilized cells were incubated with z-tagged importin-β (as a positive control) or with z-RanBP7. The binding of the z-tagged proteins was visualized with fluorescent IgG added to the import reaction. Fig. 8 shows the fluorescent staining as recorded with a confocal microscope. Strikingly, when z–importin-β or z-RanBP7 were present, the typical NPC staining pattern was observed.

RanBP7 could bind directly to NPCs or only in a complex with importin-β. In the latter case, the RanBP7–NPC interaction should be importin-β dependent. Permeabilized cells still contain endogenous importin-β, however only 10–20% of the available importin-β binding sites at the NPC are occupied by the endogenous protein (Görlich et al., 1995). If RanBP7 binding to the NPC would be strictly importin-β dependent, it should be stimulated by exogenous importin-β. However, NPC binding of z-RanBP7 was not increased but even lower if a 1:1 complex with nontagged importin-β was preformed and completely competed by a 10-fold excess of importin-β. Fig. 8 also shows that RanBP8 is NPC binding, and again, this binding is competed by excess of importin-β.

The data already suggest that RanBP7 binds to NPC not via importin-β but directly and to the same sites as importin-β. However, the interpretation of the competition is somewhat complicated by the fact that at least 3 species have to be considered, RanBP7, importin-β, and the dimeric complex of the two. We therefore wanted to know if a transport receptor with no affinity for RanBP7 would also compete with RanBP7 for NPC binding.

Fig. 9 shows that importin-β does not bind to itself or to transportin but binds strongly to RanBP7 and about four times less efficiently to RanBP8. Transportin, in turn, has no detectable affinity for either importin-β or RanBP7. We therefore chose transportin for the next competition experiment, in which importin-β, transportin, and RanBP7 were each directly fluorescein labeled and subjected at 30 nM to NPC binding. Importin-β was the positive control in this experiment. Transportin also showed a clear NPC binding (it should be noted that transportin accumulates inside the nuclei if added at a higher concentration, probably because it then saturates its own export out of the nucleus). Strikingly, the transportin signal at the nuclear envelope could be competed by unlabeled RanBP7. Fluorescent RanBP7 gave a very clear nuclear pore staining, which could be competed by unlabeled RanBP7 itself or by transportin.

As a consequence of the competition for NPC binding between the different transport mediators, excess of one transport receptor should compete the transport mediated by another one. Indeed, we have previously shown that dominant-negative importin-β mutants or excess of wild-type importin-β inhibit mRNA and U snRNA export, probably by saturating common binding sites at the nuclear pore complex (Kutay et al., 1997). Fig. 11 shows that RanBP7 also competes mRNA and U snRNA export, most likely at the level of NPC binding. As for importin-β, the export of tRNA is not affected at this concentration.